Pfizer's stock rose 0.48% in its latest trading session, outperforming the S&P 500's 0.13% uptick, while other indices ...

In the latest trading session, Pfizer (PFE) closed at $22.15, marking a +0.48% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.13% for the day. On the other ...

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

Sell Now on ET Now offers expert stock market tips, helping investors navigate market trends. The show addresses viewer queries, providing insights on buying and selling strategies, and offers timely ...

Pfizer (NYSE:PFE) recently announced the cessation of Danuglipron's development, an event that coincided with a 3% decline in ...

Here's why the stock is worth considering today. The Trump administration has so far exempted pharmaceuticals from its announced tariffs, but the industry has faced repeated threats of future tariffs.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Pfizer has discontinued its experimental weight-loss pill danuglipron after a trial patient experienced potential ...

Goldman maintains two custom equity baskets, each with 50 stocks from the Russell 1000 Index, to monitor this trend. The firm rebalanced both baskets, including the High Liquidity (GSTHLLIQ) portfolio ...

With trade war volatility off the charts, investors are hunting for safety in safe dividend stocks. That’s because dividend ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other cheap NYSE stocks. On March ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...